This session focuses on imaging-guided ultralow contrast PCI techniques designed to minimize contrast-induced nephropathy risk. It includes IVUS-guided strategies for distal left main bifurcation PCI, zero-contrast interventions in renal transplant patients, and precision stent placement without contrast use, emphasizing safety, precision, and frugality in contemporary PCI...

This session highlights the critical role of intracoronary imaging, particularly IVUS, in guiding complex percutaneous coronary interventions. It presents techniques such as IVUS-guided puncture of neo-ostia, stent implantation for ostial lesions, and innovative procedural methods like the Heart POTTER technique, underscoring the importance of precise imaging...

This session evaluates percutaneous coronary intervention (PCI) in the context of cardiogenic shock, discussing both possibilities and limitations. It features complex cases including Impella-supported rotablation in elderly patients, microaxial flow pump use, and challenging interventions in young patients with multivessel chronic total occlusions, providing insights into...

This session addresses procedural challenges in mitral valve interventions, including valve-in-valve, valve-in-ring, and valve replacement techniques. It covers lifetime management of patients with atrial fixated transcatheter mitral valve replacement (TMVR), approaches to recurrent mitral regurgitation, complex valve-in-valve cases, and hybrid strategies for valve-in-ring implantation, highlighting innovative...

Martin Bergmann reviews the evolving evidence for LAAC, examining how recent landmark trials such as OPTION, CLOSURE‑AF and CHAMPION‑AF are reshaping patient selection and expanding the role of LAAC across a broader spectrum of patients with atrial fibrillation.

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.